New data about Zolgensma, the one-time gene therapy for children with spinal muscular atrophy (SMA), demonstrate age-appropriate development ...
https://www.google.com/url?rct=j&sa=t&url=https://smanewstoday.com/news-posts/2021/06/23/developmental-milestones-sma-infants-new-data-zolgensma-trials/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGT_snTNYMtsUf-xsgRCvQp0cEyaQ
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.